BeiGene Newsroom

BeiGene Analyst Ratings

BenzingaApr 28 11:47 ET

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), BeiGene (ONC) and BioNTech SE (BNTX)

TipRanksApr 28 06:58 ET

TD Cowen Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $334

Moomoo NewsApr 25 03:31 ET

BeiGene Price Target Maintained With a $334.00/Share by TD Securities

Dow JonesApr 24 11:18 ET

BeiGene (ONC) Receives a Buy From TD Cowen

TipRanksApr 24 07:55 ET

BeiGene Analyst Ratings

BenzingaApr 21 12:05 ET

JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $317

BenzingaApr 21 12:05 ET

BeiGene Analyst Ratings

BenzingaApr 16 10:51 ET

Guggenheim Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $348

Moomoo NewsApr 10 08:32 ET

RBC Capital Initiates BeiGene(ONC.US) With Buy Rating, Announces Target Price $312

Moomoo NewsApr 8 02:33 ET

BeiGene Analyst Ratings

BenzingaApr 7 11:00 ET

RBC Initiates BeiGene at Outperform With $312 Price Target

MT NewswiresApr 7 06:38 ET

JMP Securities Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $348

Moomoo NewsApr 4 06:31 ET

BeiGene's Strategic Positioning and Growth Potential: A Buy Recommendation by Reni Benjamin

TipRanksApr 4 00:46 ET

BofA Securities Maintains BeiGene(ONC.US) With Buy Rating

Moomoo NewsMar 25 02:32 ET

Bank of America Securities Keeps Their Buy Rating on BeiGene (ONC)

TipRanksMar 24 09:12 ET

Bernstein Maintains BeiGene(ONC.US) With Hold Rating, Raises Target Price to $259

Moomoo NewsMar 13 02:33 ET

Bernstein Sticks to Their Hold Rating for BeiGene (ONC)

TipRanksMar 12 21:58 ET

JMP Securities Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $348

Moomoo NewsMar 4 14:31 ET

BeiGene's Strong Market Position and Growth Potential: A Buy Rating by Reni Benjamin

TipRanksMar 4 13:41 ET